Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters
Clinical trial NCT01390220 · TERMINATED
Trial details
- NCT number
- NCT01390220
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2017-03-01
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.